Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
2004 4
2005 1
2006 7
2007 6
2008 3
2009 1
2010 3
2011 5
2012 1
2013 2
2014 3
2015 1
2016 1
2017 4
2018 4
2019 7
2020 3
2022 2
2024 1
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Huntingtin Expression in Patients with Huntington's Disease.
Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel SA, Paz E, Smith AV, Bennett CF, Lane RM; Phase 1–2a IONIS-HTTRx Study Site Teams. Tabrizi SJ, et al. N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6. N Engl J Med. 2019. PMID: 31059641 Clinical Trial.
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study.
Ellenbogen AL, Poewe W, Espay AJ, Simuni T, Gurevich T, Yardeni T, Lopes N, Sasson N, Case R, Stocchi F; BeyoND study group. Ellenbogen AL, et al. Parkinsonism Relat Disord. 2025 Mar;132:107293. doi: 10.1016/j.parkreldis.2025.107293. Epub 2025 Jan 16. Parkinsonism Relat Disord. 2025. PMID: 39884033 Free article. Clinical Trial.
Longitudinal evaluation of polyneuropathy in Parkinson's disease.
Kwon EH, Bieber A, Schülken P, Müller K, Kühn E, Averdunk P, Kools S, Hilker L, Kirchgässler A, Ebner L, Ortmann L, Basner L, Steininger J, Kleinz T, Motte J, Fisse AL, Schneider-Gold C, Gold R, Scherbaum R, Muhlack S, Tönges L, Pitarokoili K. Kwon EH, et al. Among authors: muhlack s. J Neurol. 2024 Sep;271(9):6136-6146. doi: 10.1007/s00415-024-12579-8. Epub 2024 Jul 26. J Neurol. 2024. PMID: 39060619 Free PMC article.
Emerging Immunotherapies for Parkinson Disease.
Zella SMA, Metzdorf J, Ciftci E, Ostendorf F, Muhlack S, Gold R, Tönges L. Zella SMA, et al. Among authors: muhlack s. Neurol Ther. 2019 Jun;8(1):29-44. doi: 10.1007/s40120-018-0122-z. Epub 2018 Dec 11. Neurol Ther. 2019. PMID: 30539376 Free PMC article. Review.
Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.
Pesch B, Casjens S, Woitalla D, Dharmadhikari S, Edmondson DA, Zella MAS, Lehnert M, Lotz A, Herrmann L, Muhlack S, Kraus P, Yeh CL, Glaubitz B, Schmidt-Wilcke T, Gold R, van Thriel C, Brüning T, Tönges L, Dydak U. Pesch B, et al. Among authors: muhlack s. Cells. 2019 Jan 29;8(2):96. doi: 10.3390/cells8020096. Cells. 2019. PMID: 30699914 Free PMC article.
55 results